Debrisoquine
| |
| Names | |
|---|---|
| IUPAC name
1,2,3,4-tetrahydroisoquinoline-2-carboximidamide
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
| KEGG | |
| MeSH | Debrisoquine |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C10H13N3 | |
| Molar mass | 175.23032 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
|
WikiDoc Resources for Debrisoquine |
|
Articles |
|---|
|
Most recent articles on Debrisoquine Most cited articles on Debrisoquine |
|
Media |
|
Powerpoint slides on Debrisoquine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Debrisoquine at Clinical Trials.gov Clinical Trials on Debrisoquine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Debrisoquine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Debrisoquine Discussion groups on Debrisoquine Patient Handouts on Debrisoquine Directions to Hospitals Treating Debrisoquine Risk calculators and risk factors for Debrisoquine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Debrisoquine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Debrisoquine is a derivative of guanidine. It is an antihypertensive drug similar to guanethidine. Debrisoquine is frequently used for phenotyping the CYP2D6 enzyme, a drug metabolizing enzyme.
